NCT06368193
The Neuralert Stroke Monitor Pilot Trial
StatusRecruiting
PhaseNot applicable
SponsorNeuralert Technologies LLC
Primary completion (estimated)
At risk: Primary completion moved at least 1 year 6 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from May 1, 2026 to Nov 14, 2027 Show 4 more changesShow less
- Eligibility criteria expanded, about 16 words
- Study completion pushed from May 1, 2027 to Nov 14, 2028
- Secondary endpoints: details revised at 1 of 2 entries
- Publications: details revised at 1 of 1 entry
- Minor Study arms: 2 to 1v5
Notable Phase: Phase 2 to Not applicablev4 Show 5 more changesShow less
- Enrollment target: 20 to 50
- Eligibility criteria expanded, about 21 words
- Start date changed from estimate of Nov 10, 2024 to Dec 12, 2024
- Site contact updated
- Study arms: 1 to 2
- Notable Trial status: Not Yet Recruiting to Recruiting
- Site details revised
- Notable Start date: May 1, 2024 to Nov 10, 2024
- Primary endpoints: 1 to 2
- Secondary endpoints: 3 to 2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Time to Nursing Response
Timeframe: Up to 5 days post patient surgery
Time to Generate Alert
Timeframe: Up to 5 days post patient surgery
Secondary (2)
Number of Strokes Identified
Device Tolerability
Arms and interventions
Cardiac Surgery Patients OR Neurology PatientsExperimental
Devices: Neuralert Monitor
Sites
1 site in 1 country
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania, United States